Author:
Wang Chi,Jiang Zhen-yu,Wang Jing,Liu Jia-xin,Nian Yuan-yuan,Lixia-Liu ,Dang Tong,Meng Xian-mei
Abstract
AbstractExcessive cholesterol in the liver is harmful for our health and may cause many diseases, such as fatty liver disease. Many studies in human and animal models have reported that royal jelly (RJ) can be used to treat atherosclerosis. However, the real mechanisms behind this action is unclear. In this study, we investigated the effectivity of RJ on gene expression of squalene epoxidase (SE) a major enzyme involved in cholesterol biosynthesis in HepG2 cells. We found that the expression of SE was decreased in response to RJ treatment. We also found that the origin of the RJ affected its strength. To find out the active ingredient of RJ in cholesterol suppression, we separated RJ into two parts based on the molecular weights using ultrafiltration membrane. We found that the fraction < 10kDa from RJ had comparable effect on SE expression, especially its water-soluble part. Taken together, we think RJ suppresses cholesterol by decreasing SE gene expression in liver. The active ingredient of RJ in this action is < 10kDa in water-soluble form.
Publisher
Cold Spring Harbor Laboratory
Reference23 articles.
1. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
2. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: An epidemiological survey[J];World J Gastroenterol,2003
3. Epidemiological analysis of alcoholic and non-alcoholic fatty liver in Shanxi and Gansu province[J];Chin J Gastroenterol Hepatol,2007
4. Epidemiology and analysis on risk factors of non-infectious chronic diseases in adults in northeast China[J];J Jilin Univ(Med Edit),2011
5. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu[J];Biomed Environ Sci,2012